AI Neuro-Disorder Detection and Treatment Startup BrainQ Technologies Raises $8.8 Million

BrainQ develops a detection and non-invasive treatment technology aimed to help patients with paralysis move their limbs

Jerusalem-based medical startup BrainQ Technologies Ltd. announced on Tuesday it had raised $8.8 million in funding from investors including Qure Ventures, a venture capital fund of Jerusalem-headquartered equity crowdfunding platform OurCrowd, Russian businessman Roman Abramovich’s Norma Investments Ltd., and Tokyo-based IT-Farm.

 

For daily updates, subscribe to our newsletter by clicking here.

 

BrainQ develops a headset that utilizes electromagnetic fields and artificial intelligence algorithms to detect and treat neuro-disorders such as stroke and spinal cord injury, and promote the natural recovery of patients’ brains, according to the company’s statements.

 

BrainQ. Photo: PR

 

BrainQ’s technology scans for movements in a patient's central nervous system and creates a tailored, non-invasive treatment protocol designed to help paralyzed patients move their limbs.

 

Related stories:

• Israel’s Life Sciences Industry Is Dominated by Small Scale Startups
• Japan’s Hoya Corporation Invests in Endoscopy Company 3NT Medical
• CVC in Talks to Buy Medical Laser Company Lumenis

Founded in 2011 by Yotam Drechsler, Yaron Segal, and Esther Shohami, BrainQ employs a ten-person team and is currently conducting clinical trials in Israel. The company said in a statement it would use the funding to support additional clinical trials and to further develop and commercialize its technology.

 

BrainQ was selected for Google’s AI startup accelerator in San Francisco in November 2017.